Verge Genomics Names Robert Scannevin, Ph.D., Chief Scientific Officer

SAN FRANCISCO--(BUSINESS WIRE)--Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-in-human genomic platform with machine learning, announced today that Robert Scannevin, Ph.D., will join the company as Chief Scientific Officer. Reporting directly to Alice Zhang, Co-founder and Chief Executive Officer, Dr. Scannevin will...

Click to view original post